Christoph H Westphal - Net Worth and Insider Trading
Christoph H Westphal Net Worth
The estimated net worth of Christoph H Westphal is at least $17 Million dollars as of 2024-11-13. Christoph H Westphal is the 10% Owner of TScan Therapeutics Inc and owns about 2,315,423 shares of TScan Therapeutics Inc (TCRX) stock worth over $13 Million. Christoph H Westphal is the Director of Momenta Pharmaceuticals Inc and owns about 76,648 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $4 Million. Christoph H Westphal is also the Executive Chairman of Verastem Inc and owns about 79,692 shares of Verastem Inc (VSTM) stock worth over $349,848. Besides these, Christoph H Westphal also holds Millendo Therapeutics Inc (MLND) , Salarius Pharmaceuticals Inc (SLRX) . Details can be seen in Christoph H Westphal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christoph H Westphal has not made any transactions after 2021-07-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christoph H Westphal
Christoph H Westphal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christoph H Westphal owns 7 companies in total, including Salarius Pharmaceuticals Inc (SLRX) , Verastem Inc (VSTM) , and Millendo Therapeutics Inc (MLND) among others .
Click here to see the complete history of Christoph H Westphal’s form 4 insider trades.
Insider Ownership Summary of Christoph H Westphal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2018-10-16 | 10 percent owner |
| VSTM | Verastem Inc | 2014-12-19 | director & 10 percent owner & President & Chief Exec Officer |
| MLND | Millendo Therapeutics Inc | 2014-03-07 | director & 10 percent owner |
 | | 2005-05-26 | director |
| | 2004-05-27 | director & 10 percent owner |
| | 2013-06-07 | director & 10 percent owner |
| | 2021-07-20 | director & 10 percent owner |
Christoph H Westphal Latest Holdings Summary
Christoph H Westphal currently owns a total of 5 stocks. Among these stocks, Christoph H Westphal owns 2,315,423 shares of TScan Therapeutics Inc (TCRX) as of July 20, 2021, with a value of $13 Million and a weighting of 74.1%. Christoph H Westphal owns 76,648 shares of Momenta Pharmaceuticals Inc (MNTA) as of June 25, 2004, with a value of $4 Million and a weighting of 23.71%. Christoph H Westphal also owns 79,692 shares of Verastem Inc (VSTM) as of December 19, 2014, with a value of $349,848 and a weighting of 2.06%. The other 2 stocks Millendo Therapeutics Inc (MLND) , Salarius Pharmaceuticals Inc (SLRX) have a combined weighting of 0.13% among all his current holdings.
Latest Holdings of Christoph H Westphal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2021-07-20 | 2,315,423 | 5.43 | 12,572,747 |
| MNTA | Momenta Pharmaceuticals Inc | 2004-06-25 | 76,648 | 52.48 | 4,022,487 |
| VSTM | Verastem Inc | 2014-12-19 | 79,692 | 4.39 | 349,848 |
| MLND | Millendo Therapeutics Inc | 2014-03-07 | 20,122 | 1.06 | 21,329 |
| SLRX | Salarius Pharmaceuticals Inc | 2018-10-16 | 788 | 1.49 | 1,174 |
Holding Weightings of Christoph H Westphal
Christoph H Westphal Form 4 Trading Tracker
According to the SEC Form 4 filings, Christoph H Westphal has made a total of 1 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 133,333 shares on July 20, 2021, which cost Christoph H Westphal around $2 Million.
According to the SEC Form 4 filings, Christoph H Westphal has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the acquisition of 160,000 shares on June 25, 2004, which cost Christoph H Westphal around $1 Million.
According to the SEC Form 4 filings, Christoph H Westphal has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 125 shares on December 19, 2014, which cost Christoph H Westphal around $12,750.
More details on Christoph H Westphal's insider transactions can be found in the Insider Trading History of Christoph H Westphal table.Insider Trading History of Christoph H Westphal
- 1
Christoph H Westphal Trading Performance
GuruFocus tracks the stock performance after each of Christoph H Westphal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christoph H Westphal is -6.98%. GuruFocus also compares Christoph H Westphal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christoph H Westphal within 3 months outperforms 19 times out of 76 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christoph H Westphal's insider trading performs compared to the benchmark.
Performance of Christoph H Westphal
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.56 | | | | | |
| Relative Return to S&P 500(%) | -0.98 | | | | | |
Christoph H Westphal Ownership Network
Ownership Network List of Christoph H Westphal
Ownership Network Relation of Christoph H Westphal
Christoph H Westphal Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Christoph H Westphal is the 10 percent owner of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Christoph H Westphal Mailing Address
Above is the net worth, insider trading, and ownership report for Christoph H Westphal. You might contact Christoph H Westphal via mailing address: C/o Alnylam Pharmaceuticals, Inc, 300 Third Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
